By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.
-
-
SIROLIMUS (Generic for RAPAMUNE)
- QTY 90
- 1 MG
- Tablet
- Near 66064
SIROLIMUS (sir OH li mus) prevents the body from rejecting an organ transplant. It works by lowering the body's immune system response. This helps the body accept the donor organ. It is also used to treat lymphangioleiomyomatosis (LAM), a condition that affects the lungs, kidneys, and lymph nodes. It belongs to a group of medications called immunosuppressants.
Change Location
Set Price Drop Alert for:
SIROLIMUS (Generic for RAPAMUNE)
- QTY 90
- 1 MG
- Tablet
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
SIROLIMUS (Generic for RAPAMUNE)
- QTY 90
- 1 MG
- Tablet
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
SIROLIMUS (Generic for RAPAMUNE) Lifestyle Interactions
-
Glipizide 10mg, Oral tablet
• Interaction: Alcohol• Severity: Major• Notes for Consumers: Do not drink alcohol while taking this medication. Drinking alcohol while taking this medication increases the risk for a dangerous decrease in your blood sugar (hypoglycemia). Contact your care team if you experience tremors or shaking, anxiety, sweating, cold or clammy skin, confusion, dizziness, or a rapid heartbeat.• Notes for Professionals: Patients should be advised to avoid or limit alcohol ingestion when treated with sulfonylureas. Alcohol ingestion increases hypoglycemic risk. In some patients, hypoglycemia can be prolonged. Patients should be educated regarding the signs, symptoms, and self-management of delayed hypoglycemia after drinking alcohol, especially when using sulfonylureas. The importance of glucose monitoring after drinking alcoholic beverages to reduce hypoglycemia risk should be emphasized.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
